Related Experiment Video

Updated: Jun 27, 2026

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

Enzyme-linked immunosorbent assay method for detection of cytomegalovirus strain-specific antibody responses

Zdenek Novak1, Shannon A Ross, Raj Kumar Patro

  • 1Department of Pediatrics, The University of Alabama at Birmingham, Birmingham, Alabama 35233, USA. zdnovak@peds.uab.edu

Clinical and Vaccine Immunology : CVI
|November 29, 2008
PubMed

Insights

Detecting cytomegalovirus (CMV) strain-specific antibodies is challenging. A new enzyme-linked immunosorbent assay reliably detects antibodies to CMV glycoproteins H and B, aiding in identifying CMV reinfections.

Area of Science:

  • Virology
  • Immunology
  • Diagnostic Assay Development

Background:

  • Accurate detection of cytomegalovirus (CMV) strain-specific serological responses is currently limited.
  • Existing methods lack the reliability needed for differentiating CMV strains and identifying reinfections.

Purpose of the Study:

  • To develop and validate a simple, reliable enzyme-linked immunosorbent assay (ELISA) for detecting antibodies against polymorphic epitopes of CMV envelope glycoproteins H and B.
  • To assess the utility of this assay in identifying CMV strain-specific serological responses and detecting CMV reinfections.

Main Methods:

  • Development of a novel enzyme-linked immunosorbent assay (ELISA).
  • The assay targets antibodies against polymorphic epitopes on CMV glycoproteins H and B.
  • Validation of the assay for detecting serological responses to different CMV strains.

Main Results:

  • The developed ELISA method is demonstrated to be simple and reliable.
  • The assay successfully detects antibodies against polymorphic epitopes of CMV glycoproteins H and B.
  • The method shows utility in identifying serological responses to specific CMV strains.

Conclusions:

  • A reliable ELISA method for detecting CMV strain-specific antibodies has been established.
  • This assay facilitates the identification of serological responses to CMV and the detection of CMV reinfections.
  • The developed assay addresses a critical need in CMV diagnostics.

More Related Videos

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue08:08

qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue

Published on: July 9, 2014

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.